INSULET CORP (PODD) Form 8-K — Jun 25, 2026
$PODDForm 8-KItems 5.02, 7.01, 9.01Filed Jun 25, 2026, 7:06 AM ET0001145197-26-000148Original filing
Insulet Corporation appointed Jonathan J. Mazelsky as a Class II director effective July 1, 2026, with his election to be ratified by stockholders at the 2027 Annual Meeting. Mr. Mazelsky currently serves as Executive Chair of IDEXX Laboratories and formerly held the roles of President and CEO at the company.
Key figures
- Rsu grant value
- $216,548
- Annual award value
- $260,000
Price after filing
1 day: +3.3%7 days: +10.5%30 days: +6.4%
Close on the filing date to close N calendar days later (from $148.88). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.